Filtros de búsqueda

Lista de obras de Michael R McClung

A National Random Survey of Bone Mineral Density Reporting in the United States

artículo científico publicado en 2002

A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group.

artículo científico publicado en 1996

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

artículo científico publicado en 2005

A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data

artículo científico publicado en 2012

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.

artículo científico publicado en 2012

Acute Parathyroid Hormone Secretory Dynamics: Hormone Secretion from Normal Primate and Adenomatous Human Tissue in Response to Changes in Extracellular Calcium Concentration*

article

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

artículo científico publicado en 1998

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

artículo científico publicado en 1999

Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2002

Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group

artículo científico publicado en 2000

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

artículo científico publicado en 1995

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis ⬇️

artículo científico publicado el 1 de noviembre de 2010

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations

artículo científico publicado en 2010

Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions

artículo científico publicado en 2006

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

artículo científico publicado en 2010

Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond

artículo científico publicado en 2009

Assessment of bone status using speed of sound at multiple anatomical sites

scientific article published on 01 October 2001

Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study

artículo científico publicado en 2002

Asymptomatic neonatal familial hypercalcemia

artículo científico publicado en 1982

Automated evaluation of hip axis length for predicting hip fracture

artículo científico publicado en 1994

Bilateral comparison of femoral bone density and hip axis length from single and fan beam DXA scans

artículo científico publicado en 1995

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday

artículo científico publicado en 2012

Bisphosphonates

article

Bisphosphonates

scientific article published on 01 March 2003

Bisphosphonates and Osteonecrosis of the Jaw

artículo científico publicado en 2006

Blood pressure and calcium intake are related to bone density in adult males.

artículo científico publicado en 1999

Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group.

artículo científico publicado en 1996

Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.

artículo científico publicado en 2008

Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation

scientific article published on 19 May 2006

Bone safety with risedronate: histomorphometric studies at different dose levels and exposure

artículo científico publicado en 2014

Calcium and cholecalciferol: effects of small supplements in normal men.

artículo científico publicado en 1988

Changes in bone density and turnover after alendronate or estrogen withdrawal.

artículo científico publicado en 2004

Clinical risk factors and evaluation of the risk of osteoporosis in clinical practice.

artículo científico publicado en 2000

Clinical utility of anti-sclerostin antibodies

artículo científico publicado en 2017

Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry

artículo científico publicado en 1996

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with AlendronateVersusRisedronate Over Two Years

artículo científico publicado en 2006

Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC study

artículo científico publicado en 1996

Concentration of human chorionic gonadotropin in the cerebrospinal fluid of patients with germinal cell hypothalamic tumors ⬇️

artículo científico publicado el 1 de enero de 1980

Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?

artículo científico

Creation of an age-adjusted, dual-energy x-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-Hispanic US White women.

artículo científico

Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis

artículo científico publicado en 1996

Demonstration of "big" CRF (corticotrophin-releasing factor) in bovine hypophyseal stalk

artículo científico publicado en 1978

Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis.

artículo científico publicado en 2012

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

artículo científico publicado en 2009

Denosumab for the treatment of osteoporosis.

artículo científico publicado en 2017

Denosumab in postmenopausal women with low bone mineral density

artículo científico publicado en 2006

Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis.

artículo científico publicado en 2015

Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study

artículo científico publicado en 2012

Densitometry of the radius using single and dual energy absorptiometry

artículo científico

Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines.

artículo científico publicado en 1999

Discrepancies in normative data between Lunar and Hologic DXA systems

artículo científico publicado en 1996

Do current management strategies and guidelines adequately address fracture risk?

artículo científico publicado en 2006

Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers

article

Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial

scientific article published on 15 December 2010

Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

artículo científico publicado en 2001

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial

artículo científico publicado en 2008

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

artículo científico publicado en 2012

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis

artículo científico publicado en 2012

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis

artículo científico publicado en 2007

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

artículo científico publicado en 2001

Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial

article

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

artículo científico publicado en 2011

Effects of denosumab on fracture and bone mineral density by level of kidney function

artículo científico publicado en 2011

Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study

artículo científico publicado en 2013

Effects of risedronate on fracture risk in postmenopausal women with osteopenia

artículo científico publicado en 2007

Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss

artículo científico publicado en 2008

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

article

Enhanced precision with dual-energy X-ray absorptiometry

artículo científico

European guidance for osteoporosis: an American perspective

scientific article published on 01 September 2008

Evidence for a role of cyclic AMP-dependent protein kinase in TSH action

artículo científico publicado en 1977

Evidence that hypothalamic hypophysiotropic hormones (CRF, TRF) exist as large proteins in vivo

artículo científico publicado en 1978

Evidence that increased calcium intake does not prevent early postmenopausal bone loss

article

Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease

artículo científico publicado en 2001

FAMILIAL HYPERCHOLESTEROLAEMIA AND PRIMARY HYPOTHYROIDISM: COEXISTENCE OF BOTH DISORDERS IN A YOUNG WOMAN WITH SEVERE HYPERCHOLESTEROLAEMIA

scientific article published on 01 February 1981

Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab.

artículo científico publicado en 2014

Femoral strength in osteoporotic women treated with teriparatide or alendronate

artículo científico publicado en 2011

Fine-Needle Aspiration Cytology in the Preoperative Diagnosis of Thyroid Nodules

scientific article published on 01 September 1977

Fracture risk remains reduced one year after discontinuation of risedronate

artículo científico publicado en 2007

Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis

artículo científico publicado en 1989

How does raloxifene reduce fracture risk?

artículo científico publicado en 2002

Hyperparathyroidism and pregnancy

artículo científico publicado en 1983

Hypochlorite radioiodination of parathyroid peptides (hPTH1-34, [Tyr43]hPTH44-68).

artículo científico publicado en 1985

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.

artículo científico publicado en 2013

Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab.

artículo científico publicado en 2013

In Memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962–February 22, 2012).

artículo científico publicado en 2012

In memoriam: Sergio Ragi-Eis, MD.

artículo científico publicado en 2012

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

article

Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies

artículo científico publicado en 2006

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

article

Is altered bone health part of the metabolic syndrome?

artículo científico publicado en 2010

Lebanese guidelines for osteoporosis assessment and treatment: who to test? What measures to use? When to treat?

artículo científico publicado en 2005

Looking for answers in all the wrong places*

artículo científico publicado en 2007

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

artículo científico publicado en 1999

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

artículo científico publicado en 2010

Measurement of body composition in the elderly: dual energy x-ray absorptiometry, underwater weighing, bioelectrical impedance analysis, and anthropometry

article

Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis

artículo científico publicado en 1987

Mid-molecule parathyroid hormone assay comparison

artículo científico publicado en 1986

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

scientific article published on 01 July 1999

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results

artículo científico publicado en 2007

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

artículo científico publicado en 2005

Multisite Bone Ultrasound Measurement on North American Female Reference Population

article

New developments in osteoporosis

artículo científico publicado en 1997

Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence

artículo científico publicado en 2013

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

article

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density

artículo científico publicado en 2010

Official positions of the international society for clinical densitometry.

artículo científico publicado en 2004

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

artículo científico publicado en 2005

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis

artículo científico publicado en 2004

Osteology: Further Debate

artículo científico publicado en 1999

Osteopenia: to treat or not to treat?

artículo científico publicado en 2005

Osteoporosis update from the 2010 santa fe bone symposium

artículo científico publicado en 2011

Osteoporosis update from the 2012 Santa Fe Bone Symposium

artículo científico publicado en 2013

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

artículo científico publicado en 2005

Parathyroid hormone for the treatment of osteoporosis

artículo científico publicado en 2004

Pathogenesis of osteoporotic hip fractures

artículo científico publicado en 2003

Physiologic and Genetic Alterations in Human Red Cell DPGM ⬇️

artículo científico publicado el 1 de enero de 1980

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.

artículo científico publicado en 2003

Postmenopausal osteoporosis: fracture risk and prevention.

artículo científico publicado en 2009

Practice guidelines on the use of bone mineral density measurements: Who to test? What measures to use? When to treat? A consensus report from the Middle East Densitometry Workshop.

artículo científico publicado en 2002

Prediction of fracture risk. I: Bone density

artículo científico publicado en 1996

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

artículo científico publicado en 1998

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies

artículo científico publicado en 2001

Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study.

artículo científico publicado en 2004

Quality control of DXA instruments in multicenter trials

artículo científico publicado en 1995

Quantitative ultrasound of the heel: Correlation with densitometric measurements at different skeletal sites

artículo científico publicado en 1994

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

artículo científico publicado en 2009

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

artículo científico publicado en 2012

Results of special studies with alendronate.

artículo científico publicado en 1999

Reversible inhibition by diamide of cyclic AMP-dependent protein kinases from bovine thyroid

artículo científico publicado en 1977

Revisiting the prevention of bone loss at menopause

artículo científico publicado en 2012

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study

artículo científico publicado en 1998

Romosozumab for the treatment of osteoporosis

artículo científico publicado en 2018

Romosozumab in Postmenopausal Women with Osteopenia

artículo científico publicado en 2014

Romosozumab in postmenopausal women with low bone mineral density.

artículo científico publicado en 2014

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

artículo científico publicado en 2004

Serum protein concentrations and bone mineral content in aging normal men.

artículo científico publicado en 1987

Technetium-thallium scintiscanning for localization of parathyroid adenomas and hyperplasia

artículo científico publicado en 1987

The clinical and epidemiologic consequences of redefining treatment criteria: who should be treated?

scientific article published on January 2009

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

artículo científico publicado en 2002

The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast

artículo científico publicado en 2003

The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program

artículo científico publicado el 1 de noviembre de 2010

The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial

artículo científico publicado en 2002

The menopause and HRT. Prevention and management of osteoporosis.

artículo científico publicado en 2003

The relationship between bone mineral density and fracture risk

artículo científico publicado en 2005

The relationship of swimming exercise to bone mass in men and women

artículo científico publicado en 1989

Therapy for Fracture Prevention

artículo científico publicado en 1999

Tiludronate therapy for Paget's disease of bone

artículo científico publicado en 1995

To FRAX or not to FRAX

artículo científico publicado en 2012

Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women. EPIC study group

artículo científico publicado en 1998

Treatment of Hyperthyroidism

artículo científico publicado en 1980

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

artículo científico publicado en 2012

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

scientific article published on 16 March 2011

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

artículo científico publicado en 2004

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

artículo científico publicado en 2007

Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis

artículo científico publicado en 2013

Urinary calcium excretion at extremes of sodium intake in normal man

artículo científico publicado en 1981

Use of Bone Densitometry Results for Decisions about Therapy for Osteoporosis

artículo científico publicado en 1996

Use of highly potent bisphosphonates in the treatment of osteoporosis

artículo científico publicado en 2003

Yearly zoledronic acid in postmenopausal osteoporosis

article

Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda